SCHEMBL355455

SCHEMBL355455

COCC(=O)N(C)c1nsc2cccc(Cl)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
KDM4E B2RXH2 5/20 0.38
LMNA P02545 3/20 0.38
HPGD P15428 3/20 0.38
MAPK1 P28482 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
HSD17B10 Q99714 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
USP2 O75604 1/20 0.37
TSHR P16473 1/20 0.37
GRM5 P41594 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MCL1 Q07820 1/20 0.36
OGG1 O15527 1/20 0.36
POLB P06746 1/20 0.34
MAPT P10636 2/20 0.34
CYP1A2 P05177 1/20 0.34
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167447 0.86 ALDH1A1 (0.40) ALDH1A1KDM4ELMNAHPGDMAPK1
SCHEMBL10167449 0.84 ALDH1A1 (0.38) ALDH1A1KDM4ELMNAHPGDMAPK1
SCHEMBL10167562 0.82 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAHPGDMAPK1
SCHEMBL350288 0.81 POLB (0.39) ALDH1A1KDM4ELMNAHPGDMAPK1
SCHEMBL4387156 0.80 POLB (0.38) ALDH1A1KDM4ELMNAHPGDMAPK1
SCHEMBL355401 0.80 HPGD (0.34) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL357050 0.80 KDM4E (0.34) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2
SCHEMBL10167565 0.79 ALDH1A1 (0.38) ALDH1A1KDM4ELMNAHPGDMAPK1
SCHEMBL357034 0.78 OGG1 (0.36) ALDH1A1KDM4ELMNAHPGDMAPK1
SCHEMBL10167454 0.77 POLB (0.35) ALDH1A1KDM4ELMNAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2064196-B1 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2012-03-14 EP disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-8119568-B2 3-amino-1,2-benzisothiazole compounds for combating animal pest II BASF SE (DE) 2012-02-21 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BASF SE (DE) 2010-01-14 US disclosed
WO-2008090048-A2 3-AMINO-1,2-BENZISOTHIAZOLE COMPOUNDS FOR COMBATING ANIMAL PEST II BASF SE (DE) 2008-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009848-A1 3-Amino-1,2-Benzisothiazole Compounds for Combating Animal Pest II BPNT1, BCAT1, TGFBR1 ALDH1A1 452/4885KDM4E 3057/4885LMNA 4034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.